Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
CLRBZ was delisted on the 16th of April, 2021.
3 hedge funds and large institutions have $161K invested in Cellectar Biosciences, Inc. Series A Warrants in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more funds holding
Funds holding: 3 → 3 (0)
6% less capital invested
Capital invested by funds: $171K → $161K (-$10K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$9.13K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$2.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $148K | -$10.9K | -18,700 | -8% |
|
|
VF
2
Virtu Financial
New York
| $10K | +$9.13K | +15,596 | New |
|
|
3
Wells Fargo
San Francisco,
California
| $3K | +$2.93K | +5,000 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$2K | -3,260 | Closed |
|
CLRBZ Hedge Fund Activity: Q3 2017 in Review
3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) for Q3 2017, worth a combined $161K — down 5.8% from $171K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CLRBZ positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $9.13K. The largest seller was Susquehanna International Group, cutting an estimated $10.9K.
- 3 institutional investors held Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $161K of Cellectar Biosciences, Inc. Series A Warrants stock for Q3 2017, down 5.8% quarter-over-quarter.
- 2 funds opened new Cellectar Biosciences, Inc. Series A Warrants positions in Q3 2017 and 1 closed out, a net change of +1 holder.
- The largest Cellectar Biosciences, Inc. Series A Warrants buyer in Q3 2017 was Virtu Financial, an estimated $9.13K added.
- The largest Cellectar Biosciences, Inc. Series A Warrants seller in Q3 2017 was Susquehanna International Group, an estimated $10.9K sold.
Based on aggregated 13F filings for Q3 2017.